Hence, although clarification of our observation requires detailed investigation, this raises the possibility of the existence of a potential TPα/TPβ signalling complex in prostate tumour cells, comprising the receptor and both PRK1 and PRK2, where PRK1 may function to facilitate binding of PRK2 to TPα/TPβ and/or PRK1. The gene discussed is PKN2; the disease is prostate neoplasm.